Dr. Itri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
64 Three Mile Harbor Drive
East Hampton, NY 11937Phone+1 908-436-7294
Education & Training
New York Medical CollegeClass of 1976, MD
Publications & Presentations
PubMed
- 65 citationsBiomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.Aditya Bardia, Sara M. Tolaney, Kevin Punie, Delphine Loirat, Mafalda Oliveira
Annals of Oncology. 2021-09-01 - 255 citationsTROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Ch...Scott T. Tagawa, Arjun Vasant Balar, Daniel P. Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot
Journal of Clinical Oncology. 2021-04-30 - 577 citationsSacituzumab Govitecan in Metastatic Triple-Negative Breast CancerAditya Bardia, Sara A. Hurvitz, Sara M Tolaney, Delphine Loirat, Kevin Punie
The New England Journal of Medicine. 2021-04-21
Press Mentions
ESMO 2020: Immunomedics Presents New Trodelvy Data in Two IndicationsSeptember 21st, 2020
Immunomedics Appoints Dr. Loretta Itri Chief Medical OfficerFebruary 14th, 2020
Immunomedics Nabs J&J Veteran for CMO as It Presses on with ADC RedoFebruary 14th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
